 REHOVOT, Israel, Sept. 5, 2019 PRNewswire -- CollPlant CLGN, a regenerative medicine company, today announced that Yehiel Tal, Chief Executive Officer will be presenting at the 21st Annual Global Rodman and Renshaw Investment Conference, sponsored by H. C. Wainwright, at the Lotte New York Palace Hotel in New York on Tuesday, September 10th, 2019 at 1:45 pm EDT. Mr. Tal will provide an overview of the Companys business, including in the fields of medical aesthetics, breast implants and 3D bioprinting of life saving organs. CollPlant is a regenerative medicine company focused on 3D bioprinting of tissues and organs and medical aesthetics. 